Actavis Plc awarded Chief Executive Officer Paul Bisaro and four top managers about $115 million in early-vested stock and retention bonuses after the U.S. generic- drug maker bought Ireland-based Warner Chilcott Plc. It was a rare instance of rewarding executives of the acquirer.
Warner Chilcott Plc is weighing options including a possible sale after receiving interest from strategic and private-equity buyers, according to people with knowledge of the matter. The shares jumped in early trading.
Actavis Inc.’s $5 billion deal to buy Warner Chilcott Plc brings in a new stable of brand-name women’s health drugs. It also comes with headquarters relocated to Ireland and lower taxes for the combined company.